Loading…
Loading…
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for PHG and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for PHG and 80,000+ other tickers.
See exactly how PHG's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for PHG and 80,000+ other tickers.
Koninklijke Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Diagnosis and Treatment; Connected Care; Personal Health; and Other. The Diagnosis and Treatment segment consists of systems, smart devices, software, and services, powered by AI-enabled solutions that support precision diagnoses and minimally invasive treatment in therapeutic areas such as cardiology, peripheral vascular, neurology, surgery, and oncology. The Connected Care segment focuses on Hospital Patient Monitoring, Sleep…
July 21, 2026 New sensor advances pulse oximetry reliability for diverse patient populations through innovation and rigorous validation. Cambridge, MASS – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced FDA 510(k) clearance of its next-generation reusable Philips SpO₂ clip sensor, reinforcing the company's ongoing commitment to providing clinicians with trusted oxygen saturation measurements that support confident care for every patient.
July 8, 2026 Newest addition to the Philips ultrasound portfolio, Alturion recently received FDA 510(k) clearance and CE mark, expanding access to advanced imaging and workflow innovation across clinical settings Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the launch of the Alturion ultrasound system with AI-powered workflow built for high-volume settings. Available in the USA and Europe following FDA 510(k) clearance and CE mark certification, Alturion helps clinicians work more efficiently, deliver consistent results, and make confident clinical decisions.
CAMBRIDGE, Mass. & SAN ANTONIO--(BUSINESS WIRE)--Royal Philips, a global leader in health technology, and University Health in San Antonio today announced a strategic contract to modernize and standardize patient monitoring through Philips' Enterprise Monitoring as a Service (EMaaS) model. The collaboration will transition University Health in San Antonio to a fully integrated Philips monitoring platform environment, supporting clinical workflows, alarm management initiatives and data-driven de.
ONTARIO, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Philips Home Access is expanding its smart deadbolt lineup with new Smart Lock & Handleset/Lever Combo options, offering homeowners a more complete way to upgrade both front-door access and entryway design.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.